Clinical trial
A Study of ADX-102 in Subjects With Allergic Conjunctivitis
NCT03012165 is registered in ClinicalTrials.gov with Aldeyra Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of ADX-102 in Subjects With Allergic Conjunctivitis
- Lead sponsor
- Aldeyra Therapeutics, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2016
- Completion date
- May 31, 2017
- Enrollment
- 154 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.